NASDAQ INC (NDAQ) 56.96 +0.39 (+0.69%)
56.96 +0.39 (+0.69%)
US6311031081 - Common Stock - Premarket: 55.2326 -1.73 (-3.03%)
Buy % Consensus
Analysts have set a mean price target of 66.75. This target is 17.19% above the current price.
NDAQ was analyzed by 22 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NDAQ.
In the previous month the buy percentage consensus was at a similar level.
NDAQ was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-09-08 | Credit Suisse | Maintains | Outperform |
| 2022-08-30 | Morgan Stanley | Maintains | Overweight |
| 2022-08-29 | Morgan Stanley | Maintains | Overweight |
| 2022-08-19 | Atlantic Equities | Downgrade | Overweight -> Neutral |
| 2022-08-17 | Rosenblatt | Initiate | Buy |
| 2022-08-12 | Deutsche Bank | Maintains | Buy |
| 2022-07-21 | Credit Suisse | Maintains | Outperform |
| 2022-07-21 | Morgan Stanley | Maintains | Overweight |
| 2022-07-19 | Morgan Stanley | Maintains | Overweight |
| 2022-07-14 | Credit Suisse | Maintains | Outperform |
| 2022-05-19 | Deutsche Bank | Maintains | Buy |
| 2022-04-21 | Deutsche Bank | Maintains | Buy |
| 2022-04-21 | Rosenblatt | Maintains | Neutral |
| 2022-04-21 | Morgan Stanley | Maintains | Overweight |
| 2022-04-14 | Rosenblatt | Maintains | Neutral |
| 2022-04-13 | Morgan Stanley | Maintains | Overweight |
| 2022-03-08 | Rosenblatt | Maintains | Neutral |
| 2022-02-18 | Deutsche Bank | Maintains | Buy |
| 2022-02-15 | Credit Suisse | Initiate | Outperform |
| 2022-02-07 | Argus Research | Upgrade | Hold -> Buy |
| 2022-01-27 | UBS | Maintains | Buy |
| 2022-01-27 | Deutsche Bank | Maintains | Buy |
| 2022-01-27 | Oppenheimer | Maintains | Outperform |
| 2022-01-27 | Rosenblatt | Maintains | Neutral |
| 2022-01-27 | Morgan Stanley | Maintains | Overweight |
| 2022-01-27 | Citigroup | Maintains | Neutral |
| 2022-01-20 | Rosenblatt | Maintains | Neutral |
| 2022-01-14 | Morgan Stanley | Maintains | Overweight |
| 2022-01-04 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2021-12-10 | Rosenblatt | Maintains | Neutral |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA